FindTrial
Sign In

ASSESSING VARIOUS FEATURES OF SKIN DARKNESS IN PARTICIPANTS

CLINICAL, DERMOSCOPIC, AND HISTOPATHOLOGICAL FEATURES OF ACQUIRED DERMAL MACULAR HYPERPIGMENTATION A CROSS SECTIONAL STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085288
Enrollment
96
Registered
2025-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

None listed

Sponsors

GSL MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) PATIENTS ATTENDING TO OUR OPD WITH ADMH OF EITHER GENDER. 2) CONSENTING FOR SKIN BIOPSY FROM LESIONAL SITE.

Exclusion criteria

Exclusion criteria: 1)PATIENTS LESS THAN 18 YEARS 2)PATIENTS WITH OTHER CAUSES OF ACQUIRED HYPERPIGMENTATION HAVING A PRECEDING INFLAMMATORY PHASE LIKE FIXED DRUG ERUPTION, DRUG INDUCED HYPERPIGMENTATION, PRURIGO PIGMENTOSA AND POST INFLAMMATORY HYPERPIGMENTATION 3)PATIENTS WHO HAVE NOT GIVEN CONSENT

Design outcomes

Primary

MeasureTime frame
THIS STUDY WILL GIVE INFORMATION ABOUT CLINICAL, DERMOSCOPIC, AND HISTOPATHOLOGICAL FEATURE OF ACQUIRED DERMAL MACULAR HYPERPIGMENTATIONTimepoint: DERMOSCOPY PICTURES WILL BE TAKEN IMMEDIATELY—

Secondary

MeasureTime frame
WE WILL BE KNOWING THE DERMOSCOPIC FEATURES OF ACQUIRED DERMAL MACULAR HYPERPIGMENTATION, WHICH HELPS TO AVOID INVASIVE PROCEDURES LIKE BIOPSY.Timepoint: DERMOSCOPY PICTURES WILL BE TAKEN IMMEDIATELY—

Countries

India

Contacts

Public ContactNARREDDY SAI SWETHA

GSL MEDICAL COLLEGE AND GENERAL HOSPITAL

vellasatyanarayana@gmail.com9963744345

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026